
|Articles|September 29, 2021
LEO Pharma and Veeva Systems Partner for Patient-centric Digital Trials
Advertisement
LEO Pharma and Veeva Systems have announced a strategic technology partnership to enable scalable digital trials that are patient-centric and paperless. LEO Pharma will utilize the integrated suite of Veeva clinical products, including eTMF, CTMS, CDMS, Site Connect, eConsent, ePRO, Virtual Visits, and eSource.
By adopting technology and business processes, LEO Pharma hopes to achieve the following:
- Significantly improved patient experience
- Increased patient diversity through decentralized trials
- Higher accuracy in clinical data
- 25% reduction in clinical trial cost
- 25% reduction in clinical trial time
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
3
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5